Reduction in Antimicrobial Use and Resistance to Salmonella, Campylobacter, and Escherichia coli in Broiler Chickens, Canada, 2013–2019

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Huber, Laura ; Agunos, Agnes ; Gow, Sheryl P. ; Carson, Carolee A. ; Van Boeckel, Thomas P.
• Description:
  Antimicrobial use contributes to the global rise of antimicrobial resistance (AMR). In 2014, the poultry industry in Canada initiated its Antimicrobial Use Reduction Strategy to mitigate AMR in the poultry sector. We monitored trends in antimicrobial use and AMR of foodborne bacteria (Salmonella, Escherichia coli, and Campylobacter) in broiler chickens during 2013 and 2019. We quantified the effect of antimicrobial use and management factors on AMR by using LASSO regression and generalized mixed-effect models. AMR in broiler chickens declined by 6%-38% after the decrease in prophylactic antimicrobial use. However, the withdrawal of individual compounds, such as cephalosporins and fluoroquinolones, prompted an increase in use of and resistance levels for other drug classes, such as aminoglycosides. Canada's experience with antimicrobial use reduction illustrates the potential for progressive transitions from conventional antimicrobial-dependent broiler production to more sustainable production with respect to antimicrobial use.
• Subjects:
  Animals Anti-Infective Agents Campylobacter Chickens Drug Resistance, Bacterial Escherichia Coli Salmonella
• Source:
  Emerg Infect Dis. 27(9):2434-2444
• Pubmed ID:
  34424161
• Pubmed Central ID:
  PMC8386787
• Document Type:
  Journal Article
• Place as Subject:
  Canada
• Location:
  North America
• Volume:
  27
• Issue:
  9
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:6d653e6b4cf5b483d7190324ab3805207c18d70417b241f201b283513ff336a0
• Download URL:
  https://stacks.cdc.gov/view/cdc/109699/cdc_109699_DS1.pdf
• File Type:
  [PDF - 3.32 MB ]